Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco Dorsey Wright Momentum ETF
PDP
|
+$591M |
| 2 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$240M |
| 3 |
Boston Scientific
BSX
|
+$194M |
| 4 |
SCHW
Charles Schwab
SCHW
|
+$193M |
| 5 |
Clarivate
CLVT
|
+$158M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.25B |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$809M |
| 3 |
Willis Towers Watson
WTW
|
+$664M |
| 4 |
AstraZeneca
AZN
|
+$658M |
| 5 |
Microsoft
MSFT
|
+$573M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.19% |
| 2 | Financials | 6.48% |
| 3 | Consumer Discretionary | 5.4% |
| 4 | Healthcare | 5.05% |
| 5 | Communication Services | 4.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3401
World Acceptance Corp
WRLD
$834M
| $632K | ﹤0.01% |
3,332
-1,421
| -30% | -$263K |
|
3402
BioLife Solutions
BLFS
$1.53B
| $630K | ﹤0.01% |
14,889
+13,246
| +806% | +$638K |
|
|
HSII
3403
DELISTED
Heidrick & Struggles
HSII
| $630K | ﹤0.01% |
14,112
-3,549
| -20% | -$150K |
|
3404
National Grid
NGG
$80.4B
| $630K | ﹤0.01% |
11,958
-28,910
| -71% | -$1.66M |
|
|
ZGNX
3405
DELISTED
Zogenix, Inc.
ZGNX
| $630K | ﹤0.01% |
41,460
+28,649
| +224% | +$448K |
|
3406
AtriCure
ATRC
$1.92B
| $629K | ﹤0.01% |
9,041
+2,741
| +44% | +$211K |
|
3407
MaxCyte
MXCT
$112M
| $629K | ﹤0.01% |
+51,851
| New | +$782K |
|
3408
Weis Markets
WMK
$1.91B
| $629K | ﹤0.01% |
11,968
-4,839
| -29% | -$262K |
|
|
VAPO
3409
DELISTED
Vapotherm, Inc. Common Stock
VAPO
| $627K | ﹤0.01% |
3,518
+1,198
| +52% | +$244K |
|
|
BGFV
3410
DELISTED
Big 5 Sporting Goods
BGFV
| $626K | ﹤0.01% |
27,166
+1,343
| +5% | +$32.9K |
|
|
CUTR
3411
DELISTED
Cutera, Inc.
CUTR
| $625K | ﹤0.01% |
13,403
+3,886
| +41% | +$192K |
|
|
SFT
3412
DELISTED
Shift Technologies, Inc. Class A Common Stock
SFT
| $625K | ﹤0.01% |
8,999
-150
| -2% | -$12K |
|
|
CADE
3413
DELISTED
Cadence Bank
CADE
| $623K | ﹤0.01% |
20,906
-72,452
| -78% | -$2.02M |
|
3414
Dime Commercial Bancshares
DCOM
$1.8B
| $621K | ﹤0.01% |
19,008
-260
| -1% | -$8.43K |
|
3415
iShares MSCI EAFE Min Vol Factor ETF
EFAV
$5.34B
| $619K | ﹤0.01% |
8,221
-5,750
| -41% | -$447K |
|
3416
Griffon
GFF
$3.95B
| $619K | ﹤0.01% |
25,177
-4
| -0% | -$95 |
|
3417
Ichor Holdings
ICHR
$2.62B
| $618K | ﹤0.01% |
15,047
-401
| -3% | -$18.3K |
|
3418
Scholastic
SCHL
$767M
| $618K | ﹤0.01% |
17,328
-211
| -1% | -$7.21K |
|
3419
Compañía de Minas Buenaventura
BVN
$7.69B
| $615K | ﹤0.01% |
90,963
+6,954
| +8% | +$53.6K |
|
|
FPAC.U
3420
DELISTED
Far Peak Acquisition Corporation Units, each consisting of one Class A ordinary share, and one-third of one redeemable warrant
FPAC.U
| $615K | ﹤0.01% |
58,500
-28,900
| -33% | -$305K |
|
3421
Photronics
PLAB
$1.79B
| $614K | ﹤0.01% |
45,076
-18,989
| -30% | -$257K |
|
3422
Collegium Pharmaceutical
COLL
$1.15B
| $613K | ﹤0.01% |
31,049
+5,902
| +23% | +$128K |
|
3423
AnaptysBio
ANAB
$1.58B
| $612K | ﹤0.01% |
22,550
-54,028
| -71% | -$1.37M |
|
3424
Inogen
INGN
$175M
| $611K | ﹤0.01% |
14,191
+1,038
| +8% | +$63.8K |
|
3425
Liberty Latin America Class A
LILA
$1.64B
| $611K | ﹤0.01% |
68,720
-96,353
| -58% | -$889K |
|
Similar funds
Citigroup's Q3 2021 Portfolio in Review
As of Q3 2021, Citigroup held 6,611 positions worth $169B, up 1.9% from $166B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Citigroup deployed $5.8B of net new capital in Q3 2021, opening 423 new positions and adding to 2,034 existing holdings. Its largest new stake was Hennessy Capital Investment Corp. VI Unit: 9,095,000 shares worth $90.5M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 12% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $2.25B trimmed.
- Citigroup's largest Q3 2021 buy was Hennessy Capital Investment Corp. VI Unit: 9,095,000 shares worth $90.5M.
- Citigroup added most to Invesco Dorsey Wright Momentum ETF in Q3 2021, an estimated $591M increase.
- Citigroup's biggest Q3 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.25B.
- Citigroup fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $809M.
- Citigroup's ten largest holdings make up 25% of its $169B portfolio in Q3 2021.
- Citigroup opened 423 new positions and closed 793 in Q3 2021.
- Citigroup's portfolio value rose 1.9% quarter-over-quarter to $169B.
Based on Citigroup's 13F filing for Q3 2021, filed 10 Nov 2021.